Penumbra PE Ratio 2014-2020 | PEN
Current and historical p/e ratio for Penumbra (PEN) from 2014 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Penumbra PE ratio as of June 01, 2020 is 233.00.
| Penumbra PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2020-06-01 | 176.03 | 161.50 | |
| 2020-03-31 | 161.33 | $1.09 | 148.01 |
| 2019-12-31 | 164.27 | $1.35 | 121.68 |
| 2019-09-30 | 134.49 | $1.26 | 106.74 |
| 2019-06-30 | 160.00 | $0.39 | 410.26 |
| 2019-03-31 | 147.01 | $0.30 | 490.03 |
| 2018-12-31 | 122.20 | $0.15 | 814.67 |
| 2018-09-30 | 149.70 | $0.22 | 680.45 |
| 2018-06-30 | 138.15 | $0.78 | 177.12 |
| 2018-03-31 | 115.65 | $0.36 | 321.25 |
| 2017-12-31 | 94.10 | $0.11 | 855.45 |
| 2017-09-30 | 90.30 | $-0.22 | 0.00 |
| 2017-06-30 | 87.75 | $-0.27 | 0.00 |
| 2017-03-31 | 83.45 | $-0.21 | 0.00 |
| 2016-12-31 | 63.80 | $-0.09 | 0.00 |
| 2016-09-30 | 75.99 | $0.04 | 1899.75 |
| 2016-06-30 | 59.50 | $0.11 | 540.91 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $6.048B | $0.547B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $137.913B | 28.00 |
| Intuitive Surgical (ISRG) | United States | $67.642B | 49.96 |
| Edwards Lifesciences (EW) | United States | $46.417B | 39.01 |
| DexCom (DXCM) | United States | $34.935B | 163.07 |
| ALCON INC (ALC) | Switzerland | $31.020B | 34.72 |
| IDEXX Laboratories (IDXX) | United States | $26.234B | 61.78 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $25.179B | 17.15 |
| Olympus (OCPNY) | Japan | $22.924B | 46.63 |
| Teleflex (TFX) | United States | $16.846B | 31.20 |
| Sysmex ADR (SSMXY) | Japan | $16.530B | 46.59 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.105B | 0.00 |
| STERIS (STE) | Ireland | $14.070B | 29.41 |
| Hologic (HOLX) | United States | $13.685B | 21.55 |
| Masimo (MASI) | United States | $12.998B | 70.64 |
| Varian Medical Systems (VAR) | United States | $11.024B | 26.74 |
| ABIOMED (ABMD) | United States | $10.066B | 54.08 |
| Globus Medical (GMED) | United States | $5.331B | 33.74 |
| Tandem Diabetes Care (TNDM) | United States | $4.998B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $4.421B | 20.28 |
| Nevro (NVRO) | United States | $4.270B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $4.017B | 30.93 |
| Wright Medical Group (WMGI) | Netherlands | $3.809B | 591.00 |
| Nihon Kohden (NHNKY) | Japan | $2.969B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.600B | 16.06 |
| LivaNova (LIVN) | United Kingdom | $2.599B | 19.59 |
| Cantel Medical (CMD) | United States | $1.792B | 17.25 |
| Glaukos (GKOS) | United States | $1.724B | 0.00 |
| OPKO Health (OPK) | United States | $1.527B | 0.00 |
| Luminex (LMNX) | United States | $1.427B | 0.00 |
| ShockWave Medical (SWAV) | United States | $1.402B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.388B | 26.91 |
| Veracyte (VCYT) | United States | $1.248B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.204B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $1.155B | 60.47 |
| Tactile Systems Technology (TCMD) | United States | $0.932B | 118.17 |
| CryoLife (CRY) | United States | $0.858B | 119.63 |
| Inogen (INGN) | United States | $0.838B | 50.00 |
| OrthoPediatrics (KIDS) | United States | $0.822B | 0.00 |
| Natus Medical (NTUS) | United States | $0.723B | 17.83 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.654B | 26.42 |
| Quotient (QTNT) | Switzerland | $0.626B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.587B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.542B | 0.00 |
| Si-Bone (SIBN) | United States | $0.497B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.462B | 0.00 |
| AxoGen (AXGN) | United States | $0.386B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.384B | 25.52 |
| Intersect ENT (XENT) | United States | $0.363B | 0.00 |
| Vermillion (VRML) | United States | $0.318B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.318B | 0.00 |
| Fluidigm (FLDM) | United States | $0.308B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.290B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.282B | 0.00 |
| TransMedics (TMDX) | United States | $0.282B | 0.00 |
| IRadimed (IRMD) | United States | $0.280B | 30.19 |
| Semler Scientific (SMLR) | United States | $0.276B | 30.65 |
| ViewRay (VRAY) | United States | $0.258B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.201B | 54.40 |
| Sientra (SIEN) | United States | $0.194B | 0.00 |
| Accuray (ARAY) | United States | $0.190B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.100B | 0.00 |
| Restoration Robotics (VERO) | Canada | $0.095B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 38.57 |
| ConforMIS (CFMS) | United States | $0.071B | 0.00 |
| MRI Interventions (CLPT) | United States | $0.063B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.058B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.039B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.038B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.037B | 0.00 |
| Neuronetics (STIM) | United States | $0.034B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.033B | 0.00 |
| Neovasc (NVCN) | Canada | $0.032B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.022B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.019B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.016B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.015B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.015B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.012B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.010B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.010B | 0.00 |
| Dynatronics (DYNT) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.008B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.007B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.007B | 0.00 |
